Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA5 | P31644 | 1/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.37 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28060360 | 0.82 | GABRA5 (0.36) | GABRA5GABRB2 | |
| SCHEMBL6835640 | 0.79 | GABRA5 (0.37) | GABRA5GABRB2FFAR3 | |
| SCHEMBL5711305 | 0.78 | GABRA5 (0.56) | GABRA5GABRB2FFAR3 | |
| SCHEMBL27571576 | 0.75 | GABRA5 (0.34) | GABRA5GABRB2 | |
| SCHEMBL6315318 | 0.71 | THRB (0.34) | GABRA5GABRB2 | |
| SCHEMBL5914861 | 0.71 | THRB (0.34) | GABRA5GABRB2 | |
| SCHEMBL16236394 | 0.70 | GABRA5 (0.34) | GABRA5GABRB2 | |
| SCHEMBL11963155 | 0.68 | MEN1 (0.35) | — | |
| SCHEMBL13278423 | 0.67 | — | — | |
| SCHEMBL10425492 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060270857-A1 | Production methods of thiazoline compounds and optically active alpha-alkylcysteine | AJINOMOTO CO., INC. (JP) | 2006-11-30 | — | — | US | disclosed |
| EP-1721902-A1 | Production methods of thiazoline compounds and optically active alpha-alkylcysteine | Ajinomoto Co., Inc. (JP) | 2006-11-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060270857-A1 | Production methods of thiazoline compounds and optically active alpha-alkylcysteine | CTH, NAT1, AADAC | GABRA5 4295/4885GABRB2 4253/4885FFAR3 1872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.